Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 8, 2006, Pages 719-731

  Lu, Ting ^a   Achari, Yamini ^a   Sciore, Paul ^a   Hart, D A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

AP 1 Site; ER ; Estrogenic ligand; MMP 13; OA; Regulation

Indexed keywords

COLLAGENASE 3; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; LIGAND; LUCIFERASE; PLASMID VECTOR; PROTEINASE; RALOXIFENE; TAMOXIFEN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR PEA3; TRANSCRIPTION FACTOR RUNX1;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME RELEASE; EXPRESSION VECTOR; GENE CONSTRUCT; GENE MUTATION; GENETIC TRANSFECTION; HORMONE ACTION; IN VIVO STUDY; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEFICIENCY; RABBIT; RECEPTOR UPREGULATION; SYNOVIOCYTE;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGENASES; DNA; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 13; PROMOTER REGIONS (GENETICS); RABBITS; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEQUENCE DELETION; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; UTERUS;

ORYCTOLAGUS CUNICULUS;

EID: 33748779541     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.06.007     Document Type: Article

References (56)

1. Hellio Le Graverand M.P., Vignon E., Otterness I.G., and Hart D.A. Early changes in lapine menisci during osteoarthritis development: Part I: cellular and matrix alterations. Osteoarthr. Cartil. 9 1 (2001 (Jan)) 56-64
2. Englund M. Meniscal tear-A feature of osteoarthritis. Acta Orthop. Scand., Suppl. 75 312 (2004) 1-45
3. Mitchell P.G., Magna H.A., Reeves L.M., Lopresti-Morrow L.L., Yocum S.A., Rosner P.J., Geoghegan K.F., and Hambor J.E. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. Clin. Investig. 97 3 (1996) 761-768
4. Mengshol J.A., Vincenti M.P., and Brinckerhoff C.E. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res. 29 21 (2001) 4361-6172
5. Vincenti M.P., and Brinckerhoff C.E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 3 (2002) 157-164
6. Hellio Le Graverand M.P., Eggerer J., Sciore P., Reno C., Vignon E., Otterness I., and Hart D.A. Matrix metalloproteinase-13 expression in rabbit knee joint connective tissues: influence of maturation and response to injury. Matrix Biol. 19 (2000) 431-441
7. Brandt K.D., Braunstein E.M., Visco D.M., O'Connor B., Heck D., and Albrecht M. Anterior (cranial) cruciate ligament transection in the dog: a bona fide model of osteoarthritis, not merely of cartilage injury and repair. J. Rheumatol. 18 (1991) 436-446
8. Sah R.L., Yang A.S., Chen A.C., Hant J.J., Halili R.B., Yoshioka M., et al. Physical properties of rabbit articular cartilage after transection of the anterior cruciate ligament. J. Orthop. Res. 15 (1997) 197-203
9. Yoshioka M., Coutts R.D., Amiel D., and Hacker S.A. Characterization of a model of osteoarthritis in the rabbit knee. Osteoarthr. Cartil. 4 (1996) 87-98
10. Neuhold L.A., Killar L., Zhao W., Sung M.L., Warner L., Kulik J., Turner J., Wu W., Billinghurst C., Meijers T., Poole A.R., Babij P., and DeGennaro L.J. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107 (2001) 35-44
11. Li J., Liao E.Y., Dai R.C., Wei Q.Y., and Luo X.H. Effects of 17 beta-estradiol on the expression of interstitial collagenases-8 and -13 (MMP-8 and MMP-13) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in ovariectomized rat osteoblastic cells. J. Mol. Histol. 35 8-9 (2004) 723-731
12. Reginster J.Y., Kvasz A., Bruyere O., and Henrotin Y. Is there any rationale for prescribing hormone replacement therapy (HRT) to prevent or to treat osteoarthritis?. Osteoarthr. Cartil. 11 2 (2003 (Feb)) 87-91
13. Sowers M., Lachance L., Jamadar D., Hochberg M.C., Hollis B., Crutchfield M., and Jannausch M.L. The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. Arthritis Rheum. 42 3 (1999) 483-489
14. Sciore P., Frank C.B., and Hart D.A. Identification of sex hormone receptors in human and rabbit ligaments of the knee by reverse transcription-polymerase chain reaction: evidence that receptors are present in tissue from both male and female subjects. J. Orthop. Res. 16 5 (1998) 604-610
15. Richette P., Corvol M., and Bardin T. Estrogens, cartilage, and osteoarthritis. Jt. Bone Spine 70 4 (2003) 257-262
16. Tsai C.L., Liu T.K., and Chen T.J. Estrogen and osteoarthritis: a study of synovial estradiol and estradiol receptor binding in human osteoarthritic knees. Biochem. Biophys. Res. Commun. 183 3 (1992) 1287-1291
17. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., and Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277 5331 (1997) 1508-1510
18. Kumar V., and Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55 1 (1988) 145-156
19. Tremblay G.B., Tremblay A., Labrie F., and Giguère V. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor α-β heterodimeric complex. Mol. Cell. Biol. 19 3 (1999) 1919-1927
20. Cowley S.M., Hoare S., Mosselman S., and Parker M.G. Estrogen receptors α and β form heterodimers on DNA. JBC 272 32 (1997) 19858-19862
21. Webb P., Nguyen P., Valentine C., Lopez G.N., Kwok G.R., McInerney E., Katzenellenbogen B.S., Enmark E., Gustafsson J.-Å., Nilsson S., and Kushner P.J. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol. Endocrinol. 13 10 (1999) 1672-1685
22. Schultz J.R., Petz L.N., and Nardulli A.M. Cell- and ligand-specific regulation of promoters containing activator protein-1 and Sp1 sites by estrogen receptors α and β. J. Biol. Chem. 280 1 (2005) 347-354
23. Marin-Castano M.E., Elliot S.J., Potier M., Karl M., Striker L.J., Striker G.E., Csaky K.G., and Cousins S.W. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest. Ophthalmol. Visual Sci. 44 1 (2003) 50-59
24. Lee C.Y., Liu X., Smith C.L., Zhang X., Hsu H.C., Wang D.Y., and Luo Z.P. The combined regulation of estrogen and cyclic tension on fibroblast biosynthesis derived from anterior cruciate ligament. Matrix Biol. 23 5 (2004) 323-329
25. Hellio Le Graverand M.P., Vignon E., Otterness I.G., and Hart D.A. Early changes in lapine menisci during osteoarthritis development: Part II: molecular alterations. Osteoarthr. Cartil. 9 1 (2001) 65-72
26. Surazynski K., Jarzabek J., Haczynski P., Laudanski J., Palka S., and Wolczynski. Differential effects of estradiol and raloxifen on collagen biosynthesis in cultured human skin fibroblasts. Int. J. Mol. Med. 12 5 (2003) 803-809
27. Breckon J.J.W., Papaioannou S., Kon L.W.M., Tumber A., Hembry R.M., Murphy G., Reynolds J.J., and Meikle M.C. Stromelysin (MMP-3) synthesis is up-regulated in estrogen-deficient mouse osteoblasts in vivo and in vitro. J. Bone Miner. Res. 14 11 (1999) 1880-1890
28. Vincenti M.P., Coon C.I., Mengshol J.A., Yocum S., Mitchell P., and Brinckerhoff C.E. Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1). Biochem. J. 331 (1998) 341-346
29. Fournier B., Gutzwiller S., Dittmar T., Matthias G., Steenbergh P., and Matthias P. Estrogen Receptor (ER)-α, but Not ER-β, mediates regulation of the insulin-like growth factor I gene by antiestrogens. J. Biol. Chem. 276 38 (2001) 35444-35449
30. Metzger D., Berry M., Ali S., and Chambon P. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol. Endocrinol. 9 5 (1995) 579-591
31. McInerney E.M., and Katzenellenbogen B.S. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J. Biol. Chem. 271 39 (1996) 24172-24178
32. Kumar V., Green S., Stack G., Berry M., Jin J.R., and Chambon P. Functional domains of the human estrogen receptor. Cell 24;51 6 (1987 (Dec)) 941-951
33. Vincenti M.P., Coon C.I., Mengshol J.A., Yocum S., Mitchell P., and Brinckerhoff C.E. Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1). Biochem. J. 331 Pt 1 (1998) 341-346
34. Tardif G., Pelletier J.P., Dupuis M., Hambor J.E., and Martel-Pelletier J. Cloning, sequencing and characterization of the 5′-flanking region of the human collagenase-3 gene. Biochem. J. 323 (1997) 13-16
35. Selvamurugan N., Chou W.Y., Pearman A.T., Pulumati M.R., and Partridge N.C. Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J. Biol. Chem. 273 17 (1998) 10647-10657
36. Selvamurugan N., Pulumati M.R., Tyson D.R., and Partridge N.C. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1. J. Biol. Chem. 275 7 (2000) 5037-5042
37. Winchester S.K., Selvamurugan N., D'Alonzo R.C., and Partridge N.C. Developmental regulation of collagenase-3 mRNA in normal, differentiating osteoblasts through the activator protein-1 and the runt domain binding sites. J. Biol. Chem. 275 30 (2000) 23310-23318
38. Jakacka M., Ito M., Weiss J., Chien P.-Y., Gehm B.D., and Jameson J.L. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J. Biol. Chem. 276 17 (2001) 13615-13621
39. Hess J., Porte D., Munz C., and Angel P. AP-1 and Cbfa/Runt physically interact and regulate parathyroid hormone-dependent MMP-13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J. Biol. Chem. 276 23 (2001) 20029-20038
40. Wluka A.E., Davis S.R., Bailey M., Stuckey S.L., and Cicuttini F.M. Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann. Rheum. Dis. 60 4 (2001) 332-336
41. Birchfield P.C. Osteoarthritis overview. Geriatr. Nurs. 22 3 (2001) 124-130
42. Kian Tee M., Rogatsky I., Tzagarakis-Foster C., Cvoro A., An J., Christy R.J., Yamamoto K.R., and Leitman D.C. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol. Biol. Cell 15 3 (2004) 1262-1272
43. Ferguson S.E., Soslow R.A., Amsterdam A., and Barakat R.R. Comparison of uterine malignancies that develop during and following tamoxifen therapy. Gynecol. Oncol. 101 2 (2006) 322-326
44. Machado F., Rodriguez J.R., Leon J.P., Rodriguez J.R., Parrilla J.J., and Abad L. Tamoxifen and endometrial cancer. Is screening necessary? A review of the literature. Eur. J. Gynaecol. Oncol. 26 3 (2005) 257-265
45. Swerdlow A.J., and Jones M.E. British Tamoxifen Second Cancer Study Group. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J. Natl. Cancer Inst. 97 5 (2005) 375-384
46. Berry M., Metzger D., and Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9 (1990) 2811-2818
47. Katzenellenbogen B.S., Montano M.M., Le Goff P., Schodin D.J., Kraus W.L., Bhardwaj B., and Fujimoto N. Antiestrogens: mechanisms and actions in target cells. J. Steroid Biochem. Mol. Biol. 53 1-6 (1995) 387-393
48. McDonnell D.P., Dana S.L., Hoener P.A., Lieberman B.A., Imhof M.O., and Stein R.B. Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptor. Ann. N. Y. Acad. Sci. 761 (1995) 121-137
49. Bryant H.U., Glasebrook A.L., Yang N.N., and Sato M. An estrogen receptor basis for raloxifene action in bone. J. Steroid Biochem. Mol. Biol. 69 1-6 (1999) 37-44
50. Peach C.A., Carr A.J., and Loughlin J. Recent advances in the genetic investigation of osteoarthritis. Trends Mol. Med. 11 4 (2005 (Apr)) 186-191
51. Yoshihara Y., Nakamura H., Obata K., Yamada H., Hayakawa T., Fujikawa K., and Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59 6 (2000) 455-461
52. Marini S., Fasciglione G.F., Monteleone G., Maiotti M., Tarantino U., and Coletta M. A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities. Clin. Biochem. 36 4 (2003) 295-304
53. Okada Y., Shinmei M., Tanaka O., Naka K., Kimura A., Nakanishi I., Bayliss M.T., Iwata K., and Nagase H. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab. Invest. 66 6 (1992) 680-690
54. Freemont A.J., Hampson V., Tilman R., Goupille P., Taiwo Y., and Hoyland J.A. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann. Rheum. Dis. 56 9 (1997) 542-549
55. Roach H.I., Yamada N., Cheung K.S., Tilley S., Clarke N.M., Oreffo R.O., Kokubun S., and Bronner F. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 52 10 (2005) 3110-3124
56. Reno C., Marchuk L., Sciore P., Frank C.B., and Hart D.A. Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. BioTechniques 22 6 (1997 (Jun)) 1082-1086